Increased Insulin-Like Growth Factor 1 Receptor Protein Expression and Gene Copy Number in Small Cell Lung Cancer
- 1 December 2010
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 5 (12) , 1905-1911
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1Journal of Clinical Oncology, 2009
- Prognostic role of insulin‐like growth factor receptor‐1 expression in small cell lung cancerAPMIS, 2009
- High Expression Levels of Total IGF-1R and Sensitivity of NSCLC Cells In Vitro to an Anti-IGF-1R Antibody (R1507)PLOS ONE, 2009
- The Rationale and Development of Therapeutic Insulin-like Growth Factor Axis Inhibition for Lung and Other CancersClinical Lung Cancer, 2009
- Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2009
- High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patientsAnnals of Oncology, 2009
- Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of AktLung Cancer, 2008
- Phase I Dose Escalation Study of the Anti–Insulin-Like Growth Factor-I Receptor Monoclonal Antibody CP-751,871 in Patients with Refractory Solid TumorsClinical Cancer Research, 2007
- Inhibition of the IGF-I Receptor for Treatment of Cancer. Kinase Inhibitors and Monoclonal Antibodies as Alternative Approaches2006
- Regulation of survivin expression by IGF-1/mTOR signalingOncogene, 2006